No Data
No Data
PERSEUS PROTEOMICS: Financial results briefing materials for the fiscal year ending 2024/3
Perseus Proteomics FY Parent Loss Y1.10B Vs Loss Y786.00M
Perseus Proteomics Inc. (4882.TO) Japan Year Ended March 31 PARENT 2024 2023 Revenue Y100.00 mln Y94.00 mln Operating Profit (Y894.00
PERSEUS PROTEOMICS: Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Open H, Mitsui Chemicals, Mitsubishi Chemical G, WOWOW (15 days) (1380-4990)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/15 (Wed) <1380>Akigawa Pasture <1446>Candyle<1447>itbookHD <145A>ELISBE<148A>Hatch Work <149A>Shinka <150A>JSH <1514>Residence
Classicom, Confidence I, etc.
<2351>ASJ upward revision, previous fiscal year operating profit forecast 102 million yen ← 80 billion yen <3286>Trust HD shareholder benefit plan newly established <3625> tech firm earnings forecast revision, current fiscal year sales forecast 5.00 billion yen ← 6.00 billion yen <3917>formulating a medium-term management plan involving iRidge from the fiscal year ending 25/3 to the fiscal year ending 27/3 <4165> Played revised upward, sales forecast for the current fiscal year ending 10.809 billion yen ← 10.666 billion yen <43
Hammocks, CrowdWorks, etc.
<173A>Hammock SMBC Co., Ltd. Stock Ownership Ratio -% → 6.42% Reporting Obligation Date 2024/04/30 <2998>Clear Co., Ltd. Tokuyama Meisei Stock Holding Ratio 26.03% → 25.46% Reporting Obligation Occurrence Date 2024/04/30 <3900>CrowdWorks Co., Ltd. Bayley Gifford & Co. (Baillie Gifford & Co.) Stock Ownership Ratio
No Data